CD79B and diffuse large B-cell lymphoma: Contribution of EBV to DLBCL pathogenesis was proven to be marked regarding chromatin remodeling MYD88 and/or CD79B genes mutations, given that their presence is almost mutually exclusive with EBV infection, suggesting that they could represent distinct DLBCL subgroups with different oncogenic drivers [74].